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Hyaluronan Biodegradable Scaffold for Small-caliber Artery Grafting:
Preliminary Results in an Animal Model
Lepidi S, Grego F, Vindigni V, Zavan B, Tonello C, Deriu GP, Abatangelo
G, Cortivo R. Eur J Vasc Endovasc Surg 2006; 32:411-17.
Objective: To evaluate a new Hyaluronan-based graft.
Material and methods: Hyaluronan-based grafts (HYAFF 11™ tube,
diameter 2 mm, length 1.5 cm) were implanted in an end-to-end fashion in
the abdominal aorta of 15 rats. Histology, immunohistochemistry and
electron microscopy were used to evaluate the results at 7, 21, and 90 days.
Results: At day 7, new tissue was observed in the graft coming from
both the proximal and distal ends of the aorta. The luminal surface of the
regenerating tissue was covered by endothelial cells (CD34, VEGFR-2,
vWF). At day 21, regenerating tissue joined at the centre of the tube. The
neo-vessel was formed by smooth muscle cells (Myosin Light Chain Kinase)
as well as elastic, and collagen fibres. At day 90 a stable artery segment was
formed and the biomaterial was almost completely degraded. Infiltration of
neutrophils and lymphocytes was not observed. All animals survived the
observation period and there were no signs of stenoses or aneurysms.
Conclusion: The hyaluronan-based graft allowed complete regenera-
tion of a newly formed vascular tube in which all the cellular and extracellular
components are present and organized in a well defined architecture similar
to native artery.
PEG-hirudin/iloprost Coating of Small Diameter ePTFE Grafts Ef-
fectively Prevents Pseudointima and Intimal Hyperplasia Development
Heise M, Schmidmaier G, Husmann I, Heidenhain C, Schmidt J, Neuhaus
P, Settmacher U. Eur J Vasc Endovasc Surg 2006; 32:418-24.
Objectives: Small diameter PTFE grafts are prone to thrombosis and
intimal hyperplasia development. Heparin graft coating has beneficial effects
but also potential drawbacks. The purpose of this study was to evaluate the
experimental efficacy of PEG-hirudin/iloprost coated small caliber PTFE
grafts.
Methods: Thirty-six femoro-popliteal ePTFE grafts (expanded poly-
tetrafluoroethylene, diameter 4 mm) were inserted into 18 pigs. Grafts were
randomised individually for each leg and grouped for 3 groups. Group I
consisted of native ePTFE grafts, group II were grafts coated with a
polylactide polymer (PLA) without drugs and group III grafts were coated
with PLA containing a polyethylene glycol (PEG)-hirudin/iloprost combi-
nation. The follow-up period was 6 weeks. Patency rates were calculated and
development of pseudointima inside the grafts was noted. Thickness of
intimal hyperplasia at the distal anastomoses was measured using light
microscopy.
Results: Patency rates for group I were 6/9 (67%), for group II 9/10
(90%) and 12/12 (100%) for group III. In groups I and II there was a
significant reduction of blood flow proximal to the graft at graft harvest, to
2912 and 2820 ml/min respectively (both p0.01 versus preoperative
value), whilst in group III blood flow, 9921 ml/min, remained at the
preoperative level. Subtotal stenosis due to development of pseudointima
was noted in each of the native and PLA coated grafts but not in group III
grafts. Intimal hyperplasia at the distal anastomosis was lowest in group III.
Conclusions: The PEG-hirudin/iloprost coating of ePTFE prostheses
effectively reduced pseudointima and intimal hyperplasia development and
led to superior graft patency.
LegUlcer Recurrence and its Risk Factors: A Duplex Ultrasound Study
before and after Vein Surgery
Magnusson MB, Nelzén O, Volkmann R. Eur J Vasc Endovasc Surg 2006;
32:453-61.
Objectives: Assessment of risk factors for ulcer recurrence in chronic
leg ulcer patients treated by varicose vein surgery.
Design: Retrospective follow-up study.
Materials: 62 patients, 43 women and 19 men (Median56.5 years,
range 24–77) with the CEAP classifications of C5–C6 and EP (primary
venous insufficiency).
Methods: Patients underwent colour duplex ultrasound (CDU) inves-
tigation before varicose vein surgery. Post-operatively CDU, ambulatory
venous pressure (AVP) and an interview were performed. The median
clinical follow-up was 5.5 years (range 2–11 years).
Results: The estimated 5-year ulcer recurrence rate was 19% in all
patients. The risk of ulcer recurrence was significantly lower (p0.05) in legs
without residual varices or recurrence. The five year risk of ulcer recurrence
depended on the time interval between ulcer appearance and the surgical
intervention (index operation), post-operative venous axial reflux and AVP
(mmHg). More than 50% of the patients had a calculated probability of ulcer
recurrence of less than 3%, but 13% had a probability of more than 23% based
on our analysis.
Conclusions: A long history of venous ulcer is a pre- and post-
operative risk factor for recurrent ulceration. Total elimination of incompe-
tent superficial and perforator veins lowers the risk of ulcer recurrence,
whereas residual axial reflux increases the risk. Postoperative CDU is effec-
tive in identifying patients at risk of ulcer recurrence.
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